Elisabet Josefsson Selected Research

Edema (Dropsy)

3/2006

Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabet Josefsson Research Topics

Disease

12	Infectious Arthritis (Septic Arthritis) 10/2015 - 02/2004
11	Infections 01/2017 - 02/2004
9	Arthritis (Polyarthritis) 01/2015 - 11/2002
5	Inflammation (Inflammations) 01/2015 - 03/2005
5	Sepsis (Septicemia) 01/2015 - 05/2005
4	Staphylococcal Infections 08/2011 - 02/2004
3	Weight Loss (Weight Reduction) 10/2015 - 03/2005
3	Abscess 10/2015 - 09/2013
2	Disease Progression 01/2015 - 11/2011
2	Rheumatoid Arthritis 11/2011 - 01/2009
1	Persistent Infection 01/2016
1	Synovitis 01/2015
1	Necrosis 12/2014
1	Experimental Arthritis 11/2011
1	Shock 08/2011
1	Edema (Dropsy) 03/2006
1	Hypersensitivity (Allergy) 03/2006
1	Gout 03/2006

Drug/Important Bio-Agent (IBA)

8	Virulence Factors (Pathogenicity Factors)IBA 05/2008 - 11/2002
5	Membrane Proteins (Integral Membrane Proteins)IBA 12/2014 - 03/2005
5	factor AIBA 05/2008 - 02/2004
4	Fibrinogen (Factor I)FDA Link 05/2008 - 02/2004
3	Staphylococcus aureus auR protein (staphylokinase)IBA 01/2017 - 10/2010
3	Proteins (Proteins, Gene)FDA Link 08/2011 - 03/2005
3	Carrier Proteins (Binding Protein)IBA 03/2005 - 02/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2015 - 08/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 08/2011
2	PlasminogenIBA 09/2013 - 10/2010
2	Interleukin-6 (Interleukin 6)IBA 05/2008 - 03/2005
2	EnzymesIBA 02/2008 - 11/2007
2	Staphylococcal Protein A (Protein A)IBA 12/2005 - 11/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Galectin 3 (LGALS3)IBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 10/2015
1	Abatacept (Orencia)FDA Link 10/2015
1	Toll-Like Receptor 2IBA 01/2015
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2015
1	Receptor for Advanced Glycation End ProductsIBA 01/2015
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2015
1	Cloxacillin (Tegopen)FDA Link 01/2015
1	Bacterial DNAIBA 01/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2015
1	FibrinIBA 11/2011
1	Hemostatics (Antihemorrhagics)IBA 08/2011
1	Enterotoxins (Enterotoxin)IBA 08/2011
1	Tumor Necrosis Factor InhibitorsIBA 08/2011
1	Opsonin Proteins (Opsonins)IBA 03/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2009
1	MineralsIBA 01/2009
1	salicylhydroxamic acid (SHAM)IBA 01/2009
1	Collagen Type II (Type II Collagen)IBA 01/2009
1	CollagenIBA 01/2009
1	Estrogens (Estrogen)FDA Link 01/2009
1	Nonesterified Fatty Acids (NEFA)IBA 01/2009
1	sortase AIBA 02/2008
1	Messenger RNA (mRNA)IBA 02/2008
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 11/2007
1	Nucleic AcidsIBA 03/2006
1	RNA (Ribonucleic Acid)IBA 03/2006
1	SuspensionsIBA 03/2006
1	Biological ProductsIBA 03/2006
1	Uric Acid (Urate)IBA 03/2006
1	AntigensIBA 12/2005
1	SuperantigensIBA 12/2005
1	AntibodiesIBA 12/2005
1	Immunoglobulin G (IgG)IBA 12/2005
1	Tissue Adhesives (Tissue Adhesive)IBA 03/2005
1	Fibronectins (Fibronectin)IBA 03/2005
1	Ancrod (Arvin)IBA 02/2004

Therapy/Procedure

5	Therapeutics 01/2016 - 08/2011
1	Catheters 01/2016
1	Intra-Articular Injections 01/2015
1	Subcutaneous Injections 12/2014
1	Thrombolytic Therapy 11/2011